The role of microRNAs in oral lichenoid disorders. Systematic review

A Setién-Olarra1, M-L Gainza-Cirauqui, J-M Aguirre-Urizar

  • 1Oral Medicine, Oral and Maxillofacial Pathology. Department of Stomatology II, University of the Basque Country/ EHU, Leioa, 48940 Bizkaia, Spain, xabier.marichalar@gmail.com.

Abstract

Insights

Altered microRNA expression is linked to oral lichenoid disease (OLD) and its malignant transformation. Specific microRNAs (146a, 155) show potential as biomarkers for OLD.

Area of Science:

  • Biochemistry
  • Genetics
  • Oncology

Background:

  • MicroRNA dysregulation is associated with chronic inflammation and cancer development.
  • Oral potentially malignant disorders may involve aberrant microRNA expression.
  • Oral lichenoid disease (OLD) is a condition requiring updated research on its microRNA profile.

Purpose of the Study:

  • To systematically review and update current knowledge on microRNA expression profiles in OLD.
  • To identify specific microRNAs associated with OLD.

Main Methods:

  • A systematic literature search was conducted in PubMed-Medline and Scopus.
  • English literature published between 2010 and August 2016 was reviewed.
  • Keywords included: oral lichenoid disease, oral lichen planus, and microRNA.

Main Results:

  • An initial review of 25 articles was performed.
  • Twelve case-control studies met the inclusion/exclusion criteria.
  • The selected studies focused on microRNA expression in OLD.

Conclusions:

  • Oral lichenoid disease exhibits altered microRNA expression patterns.
  • MicroRNAs 146a and 155 are potential biomarkers for OLD.
  • Further research with larger cohorts is necessary to elucidate biological pathways and regulatory mechanisms of these microRNAs.